The new code of practice proposed by the UK Department of Health on access of information held by health authorities, trusts and other National Health Service bodies falls far short of the "open government" code of practice which came into force this April (Marketletters November 28 & December 5), according to the Campaign for Freedom of Information. The proposed code would allow such bodies to keep secret information that would have to be disclosed if held by the DoH, and produce "bizarre" decisions for which no logical justification can be found, it says.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze